{"id":"NCT02038036","sponsor":"Novartis Pharmaceuticals","briefTitle":"Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.","officialTitle":"Randomized, Open Label, Multicenter Phase IIIb Study Evaluating the Efficacy and Safety of Ruxolitinib Versus Best Available Therapy in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant (Response 2)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-25","primaryCompletion":"2015-09-29","completion":"2020-04-07","firstPosted":"2014-01-16","resultsPosted":"2021-07-20","lastUpdate":"2021-07-20"},"enrollment":149,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Polycythemia Vera"],"interventions":[{"type":"DRUG","name":"Best Available Therapy","otherNames":["BAT"]},{"type":"DRUG","name":"Ruxolitinib","otherNames":["INC424"]}],"arms":[{"label":"Ruxolitinib","type":"EXPERIMENTAL"},{"label":"Best Available Therapy (BAT)","type":"ACTIVE_COMPARATOR"}],"summary":"This study compared the efficacy and safety of ruxolitinib to Best Available Therapy (BAT) in patients with polycythemia vera (PV) who were hydroxyurea (HU) resistant or intolerant and did not have a palpable spleen.","primaryOutcome":{"measure":"Number of Participants Achieving Hematocrit (Hct) Control at Week 28","timeFrame":"Week 28","effectByArm":[{"arm":"Ruxolitinib","deltaMin":46,"sd":null},{"arm":"Best Available Therapy (BAT)","deltaMin":14,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":48,"countries":["Australia","Belgium","Canada","France","Germany","Hungary","India","Israel","Italy","South Korea","Spain","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["35597252","29396713","27916398"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":34,"n":74},"commonTop":["Anaemia","Pruritus","Headache","Weight increased","Arthralgia"]}}